Answers are grounded in this paper and cite their sources.
In a recent study published in Nature , Cui et al. identified intramucosal GPR15-guided regulatory CD8⁺ T (CD8⁺ T IGR ) cells and linked deleterious human GPR15 variants to impaired mucosal homing and severe early-onset inflammatory bowel disease. 1 Complementary mouse studies indicated that these cells restrain colitis predominantly via FasL-dependent elimination of inflammatory macrophages, implying a tissue-selective regulatory pathway with therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: